Comparison of BinaxNOW Influenza A&B assay and real-time reverse transcription polymerase chain reaction for diagnosis of influenza A pandemic (H1N1) 2009 virus infection in adult patients.
The BinaxNOW Influenza A&B assay was evaluated for the diagnosis of influenza A pandemic (H1N1) 2009 virus infection in 354 adult patients. The sensitivity, specificity, and positive and negative predictive values were 32%, 100%, 100%, and 67%, respectively. The analytic sensitivity of the assay was log₁₀5.0 tissue culture infective dose (TCID)₅₀/mL.